BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36781502)

  • 21. A positive feedback loop of LINC00662 and STAT3 promotes malignant phenotype of glioma.
    Ji W; Jiao J; Cheng C; Xiao Y; Shao J; Liu H
    Pathol Res Pract; 2021 Aug; 224():153539. PubMed ID: 34246852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.
    Müller S; Chen Y; Ginter T; Schäfer C; Buchwald M; Schmitz LM; Klitzsch J; Schütz A; Haitel A; Schmid K; Moriggl R; Kenner L; Friedrich K; Haan C; Petersen I; Heinzel T; Krämer OH
    Oncotarget; 2014 May; 5(10):3184-96. PubMed ID: 24833526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
    Huang H; Huang J; Yao J; Li N; Yang Z
    J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
    Tang C; Feng W; Bao Y; Du H
    Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
    Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
    J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.
    Velusamy T; Kiel MJ; Sahasrabuddhe AA; Rolland D; Dixon CA; Bailey NG; Betz BL; Brown NA; Hristov AC; Wilcox RA; Miranda RN; Medeiros LJ; Jeon YK; Inamdar KV; Lim MS; Elenitoba-Johnson KS
    Blood; 2014 Dec; 124(25):3768-71. PubMed ID: 25349176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
    Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
    Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
    Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
    Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells.
    Ding X; Fu Q; Chen W; Chen L; Zeng Q; Zhang S; He L
    Cell Biol Int; 2022 May; 46(5):840-848. PubMed ID: 35143103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-neoplastic activities of aloperine in HeLa cervical cancer cells are associated with inhibition of the IL-6-JAK1-STAT3 feedback loop.
    Chen YD; Cai FY; Mao YZ; Yang YS; Xu K; Liu XF; Fan WW; Chen W; Jiang FQ; Zhang H
    Chin J Nat Med; 2021 Nov; 19(11):815-824. PubMed ID: 34844720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling.
    Sun S; Gao J; Zhou S; Li Y; Wang Y; Jin L; Li J; Liu B; Zhang B; Han S; Ding H; Li X
    J Exp Clin Cancer Res; 2020 Nov; 39(1):252. PubMed ID: 33222697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.
    Bao W; Wang HH; Tian FJ; He XY; Qiu MT; Wang JY; Zhang HJ; Wang LH; Wan XP
    Mol Cancer; 2013 Dec; 12():155. PubMed ID: 24321270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
    Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
    J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
    Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
    J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
    Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
    Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
    Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.